Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Instructions to Keep up with Your Traded Teeth for Life span- IDF finds weapon of slain hostage Capt. Daniel Perez in booby-trapped Gaza compound
- HR exec caught on Coldplay 'kiss cam' with boss finally breaks her silence: 'I made a bad decision and had a couple of High Noons'
- Holiday season sees uptick in norovirus cases, according to CDC
- Vice President Dick Cheney’s life followed the arc of the biggest breakthroughs in cardiovascular medicine
- New Year's superstitions: Eating 12 grapes, avoiding laundry and other rituals that are said to bring good fortune
- 'Crammed into a cell with vermin at New Year'
- 3D Printers for Specialists
- The Best 20 Photography Instagram Records to Follow
